Join today and have your say! It’s FREE!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}

Join today with :


By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Sign in with existing account
Please Try Again
{{ error }}

Sign In With :


Password Hint : {{passwordHint}}
Forgot Password?
Please Try Again {{ error }}

Send my password

An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Viveve Medical Inc. VIVE

"Viveve Medical Inc designs, develops, manufactures, and markets medical devices for the non-invasive treatment of vaginal laxity. The company offers Geneveve, a non-invasive solution that includes the Viveve System, a radio frequency generator; a reusable hand piece and single-use treatment tip; and other consumable accessories. The Geneveve is indicated for use in general procedures for electrocoagulation and hemostasis in the US. The firm markets its products through sales employees and distr

View modes: 

Most Anticipated Earnings Releases for the week beginning

Check out Most Anticipated Earnings Releases for the week beginning September 30, 2019  rate and reply

it's a buy today for me

started an entry position of this one,so glta.  rate and reply

RE:RE:Price drops?

PUNT senior management and the BOD. Bigger shareholders need to bring in another team since this one is clearly inept at managing shareholder value. They are running a lifestyle company where more

RE:Price drops?

Great technology and development roll out. Main issue is management have been disrespectful to its shareholders with massive dilution and the cash bleed has no end in sight. Once it goes cash more

Price drops?

Does anyone have insight into the recent price drops (essentially from $1 to $0.80)?  I am not seeing any news that would justify it.  Even some of the price target slashes are down to $ more

Ladenburg Price Target $4/sh  rate and reply

Liberate International for SUI

Results expected around August 2019 for the international study with 99 participants.Positive results will be a catalyst for the SP barring any requirements for additonal follow ups. I am more

RE:RE:Cash Flow Positive

Nice move today. Glad I bought more on the dip. Looks like Q4 must be decent after all or funds are loading up pre Q1. Pleasant surprise!  rate and reply

RE:Cash Flow Positive

Bought more following the capital raise. Hope Q4 will be better despite the FDA spook for competitors with FDA warnings.  rate and reply

Cash Flow Positive

Management needs to outline their plan profitability or the next financings will be highly dilutive and disastrous for current shareholders. Look to Valeritas fir a great presentation... execution more


Get our FREE StockTalk Investor Guides by sector as they are released!

Stay on top of sector specific news, get industry leaders insights and our best content, delivered to your email.

You are already a member! Please enter your password to sign in.